Evidence map›Paper›PMID 40746942›Full record

ArticleTransplantation direct2025

Association of Clinical, Psychosocial, and Social Determinants of Health Factors and Liver Transplantation and Waitlist Removal for MASH.

Kelly Torosian, Fanny Delebecque, Deyna Arellano, Irine Vodkin, Veeral Ajmera, Monica Tincopa

Abstract read
In one paragraph

Article in Transplantation direct, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Exploring Disease-Specific Waitlist Outcomes in Simultaneous Liver-Kidney Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kelly TorosianDivision of Gastroenterology and Hepatology, University of San Diego, California, San Diego, CA.ORCID https://orcid.org/0000-0003-4999-4627
Fanny DelebecqueAltman Clinical Translational Research Institute, University of San Diego, California, San Diego, CA.
Deyna ArellanoAltman Clinical Translational Research Institute, University of San Diego, California, San Diego, CA.
Irine VodkinDivision of Gastroenterology and Hepatology, University of San Diego, California, San Diego, CA.
Veeral AjmeraDivision of Gastroenterology and Hepatology, University of San Diego, California, San Diego, CA.
Monica TincopaDivision of Gastroenterology and Hepatology, University of San Diego, California, San Diego, CA.ORCID https://orcid.org/0000-0002-9954-8548

Funding

San Diego Digestive Diseases Research CenterP30DK120515 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Bernd G. Schnabl · 2019 to 2026
$10.8M
A Novel Multimodal Approach to Characterize NAFLD Severity and PrognosisK23DK119460 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AJMERA, VEERAL HARESH · 2019 to 2023
$1.1M
NIDDK NIH HHS K23 DK119460NIDDK NIH HHS P30 DK120515
6 · The paper itself

Abstract

Background: Patients with metabolic dysfunction-associated steatohepatitis (MASH) have distinct medical comorbidities, psychosocial and social determinants of health (SDOH) factors that may impact liver transplantation (LT) rates. The aim of this study was to identify clinical, psychosocial and SDOH factors associated with rates of LT and LT waitlist removal based on MASH etiology. Methods: This was retrospective cohort study at a large academic transplant center. Adults listed for LT between January 2018 and December 2020 were included. Patients listed as status 1A and those with prior LT were excluded. Demographic, clinical, psychosocial and SDOH characteristics were evaluated. Factors associated with LT and LT waitlist removal were analyzed using univariate and multivariate logistic regression. Results: A total of 374 patients were included, of which 19% (n = 70) had MASH. MASH candidates more likely to be older (62 versus 57), female (63% versus 35%), and of Latino/Hispanic ethnicity (76% versus 43%). Patients with MASH had significantly lower Stanford Integrated Psychosocial Assessment for Transplant scores, substance use, years of formal education, and private insurance, and had higher percentages of long-term partners. The rate of LT and waitlist removal (including death) did not significantly differ by MASH status. Patients with MASH were significantly more likely to die on the waitlist (62% versus 27%). On multivariate analysis, male sex (odds ratio [OR], 1.74; 95% confidence interval [CI], 1.01-2.92; Conclusions: Rates of LT and LT waitlist removal did not significantly differ by MASH etiology, though patients with MASH were significantly more likely to die on the LT waitlist. There continue to be SDOH factors associated with rates of LT, with male sex and employment independently conferring higher odds of access to LT.

Identifiers

PMID40746942
PMCPMC12313088

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.